Cited 0 times in
고령 환자의 간암치료 및 감시
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 김경식 | - |
dc.contributor.author | 노승윤 | - |
dc.contributor.author | 이현웅 | - |
dc.date.accessioned | 2019-07-11T02:57:28Z | - |
dc.date.available | 2019-07-11T02:57:28Z | - |
dc.date.issued | 2018 | - |
dc.identifier.issn | 2288-8128 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/169784 | - |
dc.description.abstract | Hepatocellular carcinoma (HCC) is the third most common cancer in the digestive system based on survey of domestic cancer incidence, and the ratio of elderly aged 65 or older is expected to rise steadily, leading to a higher incidence of total hepatocellular carcinoma. The most important thing in treating these older patients with HCC is to assess the benefits and risks of the treatment in advance. In other words, the benefit of treatment should be greater than the reduction of survival period or maladjustment due to treatment. Based on these perspectives, we examined how the detailed treatment of hepatocellular carcinoma differs from that of general treatment in elderly patients. In conclusion, older age was not a definite prognostic factor of survival risk-benefit comparison in the most treatment modalities. However it should be carefully considered and approached about possible complications in treating HCC in elderly patients | - |
dc.description.statementOfResponsibility | open | - |
dc.language | Korean | - |
dc.publisher | 대한간암학회 | - |
dc.relation.isPartOf | Journal of Liver Cancer (대한간암학회지) | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.rights | https://creativecommons.org/licenses/by-nc-nd/2.0/kr/ | - |
dc.title | 고령 환자의 간암치료 및 감시 | - |
dc.title.alternative | Treatment and Surveillance of Hepatocellular Carcinoma in Elderly Patients | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Surgery (외과학교실) | - |
dc.contributor.googleauthor | 노승윤 | - |
dc.contributor.googleauthor | 이현웅 | - |
dc.contributor.googleauthor | 김경식 | - |
dc.identifier.doi | 10.17998/jlc.18.2.103 | - |
dc.contributor.localId | A00299 | - |
dc.contributor.localId | A05469 | - |
dc.contributor.localId | A03292 | - |
dc.relation.journalcode | J03078 | - |
dc.identifier.eissn | 2383-5001 | - |
dc.subject.keyword | Carcinoma, Hepatocellular | - |
dc.subject.keyword | Aged patients | - |
dc.subject.keyword | Aging | - |
dc.subject.keyword | Therapeutic | - |
dc.subject.keyword | Surveillance | - |
dc.contributor.alternativeName | Kim, Kyung Sik | - |
dc.contributor.affiliatedAuthor | 김경식 | - |
dc.contributor.affiliatedAuthor | 노승윤 | - |
dc.contributor.affiliatedAuthor | 이현웅 | - |
dc.citation.volume | 18 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 103 | - |
dc.citation.endPage | 114 | - |
dc.identifier.bibliographicCitation | Journal of Liver Cancer (대한간암학회지), Vol.18(2) : 103-114, 2018 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.